Edgewell Personal Care is expected to report fourth-quarter revenue of $479.88 million and earnings per share of $0.77, with shares trading at $29.53 against a $31.50 average analyst target. The key story for investors is the company's organic net sales growth following the strategic divestiture of its Feminine Care business to Essity.
Market participants are looking for signs of sustained recovery in the North American Sun and Skin Care categories, which returned to growth in the prior quarter. Management's outlook for fiscal year 2027 will be critical, as analysts watch for the impact of recent cost-cutting measures and advertising investments on margin expansion.